The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Recurrent glioblastoma multiforme: a review of natural history and management options
Open accessAbstract
✓ Glioblastoma multiforme (GBM) is one of the most aggressive primary brain tumors, with a grim prognosis despite maximal treatment. Advancements in the past decades have not significantly increased the overall survival of patients with this disease. The recurrence of GBM is inevitable, its management often unclear and case dependent. In this report, the authors summarize the current literature regarding the natural history, surveillance algorithms, and treatment options of recurrent GBM. Furthermore, they provide brief discussions regarding current novel efforts in basic and clinical research. They conclude that although recurrent GBM remains a fatal disease, the literature suggests that a subset of patients may benefit from maximal treatment efforts. Nevertheless, further research effort in all aspects of GBM diagnosis and treatment remains essential to improve the overall prognosis of this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
World Health Organization Classification of Tumours
Fletcher, C., van den Berg, A., & Molenaar, I. (2002) · Cited by 7,079
World Health Organization classification of tumors
Kleihues, P., & Sobin, L. H. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12<2887::aid-cncr32>3.0.co;2-f · Cited by 2,377
Shaw, E., Scott, C., Souhami, L., Dinapoli, R., Kline, R., Loeffler, J., & Farnan, N. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00507-6 · Cited by 1,608
Brem, H., Piantadosi, S., Burger, P. C., Walker, M., Selker, R., Vick, N. A., Black, K., Sisti, M., Brem, S., Mohr, G., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90755-6 · Cited by 1,389
Yung, W. K. A., Albright, R. E., Olson, J., Fredericks, R., Fink, K., Prados, M. D., Brada, M., Spence, A., Hohl, R. J., Shapiro, W., et al. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1316 · Cited by 929
Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings.
Aronen, H. J., Gazit, I. E., Louis, D. N., Buchbinder, B. R., Pardo, F. S., Weisskoff, R. M., Harsh, G. R., Cosgrove, G. R., Halpern, E. F., & Hochberg, F. H. (1994) · Radiology · doi:10.1148/radiology.191.1.8134596 · Cited by 908
Stupp, R., Dietrich, P.-Y., Ostermann, S., Pica, A., Maillard, I. P., Maeder, P., Meuli, R. A., Janzer, R. C., Pizzolato, G., Miralbell, R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1375 · Cited by 856
Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging
Sipkins, D. A., Cheresh, D. A., Kazemi, M. R., Nevin, L. M., Bednarski, M. D., & Li, K. C. P. (1998) · Nature Medicine · doi:10.1038/nm0598-623 · Cited by 850
Glial Neoplasms: Dynamic Contrast-enhanced T2*-weighted MR Imaging
Knopp, E. A., Cha, S., Johnson, G., Mazumdar, A., Golfinos, J. G., Zagzag, D., Miller, D. C., Kelly, P. J., & Kricheff, I. I. (1999) · Radiology · doi:10.1148/radiology.211.3.r99jn46791 · Cited by 596
Davis, F. G., Freels, S., Grutsch, J., Barlas, S., & Brem, S. (1998) · Journal of Neurosurgery · doi:10.3171/jns.1998.88.1.0001 · Cited by 482
In vivo Near-Infrared Fluorescence Imaging of Integrin αvβ3 in Brain Tumor Xenografts
Chen, X., Conti, P. S., & Moats, R. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1956 · Cited by 347
Survival and Functional Status after Resection of Recurrent Glioblastoma Multiforme
Barker, F. G., Chang, S. M., Gutin, P. H., Malec, M. K., McDermott, M. W., Prados, M. D., & Wilson, C. B. (1998) · Neurosurgery · doi:10.1097/00006123-199804000-00013 · Cited by 330
Lee, S. W., Fraass, B. A., Marsh, L. H., Herbort, K., Gebarski, S. S., Martel, M. K., Radany, E. H., Lichter, A. S., & Sandler, H. M. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00266-1 · Cited by 306
Gaspar, L. E., Fisher, B. J., Macdonald, D. R., Leber, D. V., Halperin, E. C., Schold, S. C., & Cairncross, J. G. (1992) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(92)91021-e · Cited by 295
Cohen, M. H., Johnson, J. R., & Pazdur, R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0722 · Cited by 282
Development of multiple lesions during radiation therapy and chemotherapy in patients with gliomas
Choucair, A. K., Levin, V. A., Gutin, P. H., Davis, R. L., Silver, P., Edwards, M. S. B., & Wilson, C. B. (1986) · Journal of Neurosurgery · doi:10.3171/jns.1986.65.5.0654 · Cited by 255
Near-Infrared Fluorescent RGD Peptides for Optical Imaging of Integrin αvβ3Expression in Living Mice
Cheng, Z., Wu, Y., Xiong, Z., Gambhir, S. S., & Chen, X. (2005) · Bioconjugate Chemistry · doi:10.1021/bc0501698 · Cited by 234
Groves, M. D., Puduvalli, V. K., Hess, K. R., Jaeckle, K. A., Peterson, P., Yung, W. K. A., & Levin, V. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1383 · Cited by 229
Black, P. M. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105233242105 · Cited by 229
Stereotactic radiosurgery (SRS): Treatment option for recurrent glioblastoma multiforme (GBM)
Combs, S. E., Widmer, V., Thilmann, C., Hof, H., Debus, J., & Schulz‐Ertner, D. (2005) · Cancer · doi:10.1002/cncr.21429 · Cited by 217
Osoba, D., Brada, M., Yung, W. K. A., & Prados, M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.7.1481 · Cited by 213
Is the long‐term survival of patients with intracranial glioblastoma multiforme overstated?
McLendon, R. E., & Halperin, E. C. (2003) · Cancer · doi:10.1002/cncr.11666 · Cited by 176
A comparison of treatment results for recurrent malignant gliomas
Nieder, C., Grosu, A. L., & Molls, M. (2000) · Cancer Treatment Reviews · doi:10.1053/ctrv.2000.0191 · Cited by 158
One week on/one week off: A novel active regimen of temozolomide for recurrent glioblastoma
Wick, W., Steinbach, J. P., Küker, W., DICHGANS, J., BAMBERG, M., & Weller, M. (2004) · Neurology · doi:10.1212/01.wnl.0000127617.89363.84 · Cited by 155
Jaeckle, K. A., Hess, K. R., Yung, W. K. A., Greenberg, H. S., Fine, H. A., Schiff, D., Pollack, I. F., Kuhn, J. G., Fink, K., Mehta, M. P., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.097 · Cited by 149
Weybright, P., Millis, K. K., Campbell, N., Cory, D. G., & Singer, S. (1998) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910390302 · Cited by 143
Colombo, F., Barzon, L., Franchin, E., Pacenti, M., Pinna, V., Danieli, D., Zanusso, M., & Palù, G. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700851 · Cited by 129
Long-term Glioblastoma Multiforme Survivors: a Population-based Study
Scott, J. N., Rewcastle, N. B., Brasher, P. M. A., Fulton, D. S., Hagen, N. A., MacKinnon, J. A., Sutherland, G. R., Cairncross, J. G., & Forsyth, P. A. (1998) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100034016 · Cited by 128
Cha, S., Knopp, E., Johnson, G., Litt, A. W., Glass, J., Gruber, M. L., Lu, S., & Zagzag, D. (2000) · PubMed · Cited by 127
Sipos, E. P., Tyler, B., Piantadosi, S., Burger, P. C., & Brem, H. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050588 · Cited by 123
Dillman, R. O., Duma, C., Schiltz, P. M., DePriest, C. B., Ellis, R. A., Okamoto, K., Beutel, L. D., de Leon, C., & Chico, S. (2004) · Journal of Immunotherapy · doi:10.1097/00002371-200409000-00009 · Cited by 119
Tuettenberg, J., Grobholz, R., Korn, T., Wenz, F. K., Erber, R., & Vajkoczy, P. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0620-5 · Cited by 114
Dynamic susceptibility contrast MRI of gliomas
Aronen, H. J., & Perkiö, J. (2002) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(02)00026-6 · Cited by 113
Combined Thalidomide and Temozolomide Treatment in Patients with Glioblastoma Multiforme
Baumann, F., Bjeljac, M., Kollias, S., Baumert, B. G., Brandner, S., Rousson, V., Yonekawa, Y., & Bernays, R. L. (2004) · Journal of Neuro-Oncology · doi:10.1023/b:neon.0000021803.01170.03 · Cited by 105
Multimodality Management of Recurrent Adult Malignant Gliomas
Rostomily, R., Spence, A. M., Duong, D. H., McCormick, K. B., Bland, M., & Berger, M. S. (1994) · Neurosurgery · doi:10.1227/00006123-199409000-00004 · Cited by 102
Pepponi, R., Marra, G., Fuggetta, M. P., Falcinelli, S., Pagani, E., Bonmassar, E., Jiricny, J., & D’Atri, S. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.043950 · Cited by 81
Practical guidelines for the treatment of malignant gliomas.
Chamberlain, M. C., & Kormanik, P. A. (1998) · PubMed Central · Cited by 80
Case—control study of stereotactic radiosurgery for recurrent glioblastoma multiforme
Mahajan, A., McCutcheon, I. E., Suki, D., Chang, E. L., Hassenbusch, S. J., Weinberg, J. S., Shiu, A. S., Maor, M. H., & Woo, S. Y. (2005) · Journal of neurosurgery · doi:10.3171/jns.2005.103.2.0210 · Cited by 79
Treatment of recurrent malignant supratentorial gliomas with carboplatin (CBDCA)
Poisson, M., P�r�on, Y., Jacques Chiras, C., & Delattre, J. (1991) · Journal of Neuro-Oncology · doi:10.1007/bf00146875 · Cited by 70
Salvage therapy in patients with glioblastoma: Is there any benefit?
Hau, P., Baumgart, U., Pfeifer, K., Bock, A., Jauch, T., Dietrich, J., Fabel, K., Grauer, O. M., Wismeth, C., Klinkhammer‐Schalke, M., et al. (2003) · Cancer · doi:10.1002/cncr.11845 · Cited by 69
Radiation Combined With Antiangiogenic and Antivascular Agents
OʼReilly, M. (2005) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2005.08.006 · Cited by 64
Brandes, A. A., Ermani, M., Basso, U., Paris, M. K., Lumachi, F., Berti, F., Amistà, P., Gardiman, M. P., Iuzzolino, P., Turazzi, S., et al. (2002) · Oncology · doi:10.1159/000065718 · Cited by 59
Deen, D. F., Chiarodo, A., Grimm, E. A., Fike, J. R., Israel, M. A., Kun, L. E., Levin, V. A., Marton, L. J., Packer, R. J., Pegg, A. E., et al. (1993) · Journal of Neuro-Oncology · doi:10.1007/bf01057041 · Cited by 55
Long-term survival in patients with supratentorial glioblastoma
Salvati, M., Cervoni, L., Artico, M., Caruso, R., & Gagliardi, F. M. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1017926603341 · Cited by 51
Sanson, M., Améri, A., Monjour, A., Sahmoud, T., Ronchin, P., Poisson, M., & Delattre, J. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00299-7 · Cited by 46
Longitudinal MicroPET Imaging of Brain Tumor Growth with F-18-labeled RGD Peptide
Chen, X. S., Park, R. J.-H., Khankaldyyan, V., Gonzales-Gomez, I., Tohme, M. S., Moats, R. A., Bading, J. R., Laug, W. E., & Conti, P. S. (2005) · Molecular Imaging and Biology · doi:10.1007/s11307-005-0024-1 · Cited by 34
Gliomas: advances in molecular analysis and characterization
Boudreau, C. R., Yang, I., & Liau, L. M. (2005) · Surgical Neurology · doi:10.1016/j.surneu.2005.03.033 · Cited by 34
Human gene therapy and imaging in neurological diseases
Jacobs, A. H., Winkler, A., Castro, M. G., & Lowenstein, P. R. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1960-3 · Cited by 24
Extending survival in gliomas: surgical resection or immunotherapy?
Hall, W. A. (2004) · Surgical Neurology · doi:10.1016/j.surneu.2003.07.005 · Cited by 23
Novel Radiation-Enhancing Agents in Malignant Gliomas
Zhang, M., & Chakravarti, A. (2005) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2005.08.004 · Cited by 23
Cited by
A neurocentric perspective on glioma invasion
Cuddapah, V. A., Robel, S., Watkins, S., & Sontheimer, H. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3765 · Cited by 831
Psychosis and autism as diametrical disorders of the social brain
Crespi, B., & Badcock, C. (2008) · Behavioral and Brain Sciences · doi:10.1017/s0140525x08004214 · Cited by 604
Mechanisms regulating glioma invasion
Paw, I., Carpenter, R. C., Watabe, K., Debinski, W., & Lo, H.-W. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.03.015 · Cited by 306
Understanding high grade glioma: Molecular mechanism, therapy and comprehensive management
Wang, Y., & Jiang, T. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.12.024 · Cited by 260
Tumor Cell Invasion in Glioblastoma
Vollmann-Zwerenz, A., Leidgens, V., Feliciello, G., Klein, C. A., & Hau, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21061932 · Cited by 257
Metadata
- Authors
- Hou, L. C., Veeravagu, A., Hsu, A. R., & Tse, V. C. K.
- Venue
- Neurosurgical Focus
- Published
- 2006-04
- Volume
- 20
- Issue
- 4
- Pages
- E3
- ISSN
- 1092-0684 (ISSN-L)
- OpenAlex
- W2110685305
- Cited by
- 275
- References
- 51
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.